Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Investigation

• Publication date

  2003-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI17215PMID 12697741PMCID PMC152939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the in vivo function of TNF‐α‐related apoptosis‐inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene‐deficient mice

  2002cited by this paper
• Sex steroids and the construction and conservation of the adult skeleton.

  2002cited by this paper
• Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis.

  2002cited by this paper
• Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men.

  2002cited by this paper
• The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation

  2002cited by this paper
• Clinical review 144: Estrogen and the male skeleton.

  2002cited by this paper
• Correlates of Osteoprotegerin Levels in Women and Men

  2002influential reference
• Estrogen and the Male Skeleton

  2002cited by this paper
• The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells

  2001cited by this paper
• Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology

  2001influential reference
• Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol.

  2001cited by this paper
• Minireview: the OPG/RANKL/RANK system.

  2001cited by this paper
• 17β-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-α.

  2001cited by this paper
• 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha.

  2001cited by this paper
• Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

  2000cited by this paper
• The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.

  2000cited by this paper
• Prostaglandin E2 Induces Expression of Receptor Activator of Nuclear Factor–κB Ligand/Osteoprotegrin Ligand on Pre‐B Cells: Implications for Accelerated Osteoclastogenesis in Estrogen Deficiency

  2000cited by this paper
• Temperature-sensitive Differential Affinity of TRAIL for Its Receptors

  2000cited by this paper
• The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.

  2000influential reference
• Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

  2000influential reference
• Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

  2000influential reference
• The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

  2000cited by this paper
• TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

  2000cited by this paper
• Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with Osteoporosis

  1999cited by this paper
• Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein‐2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte Maturation

  1999cited by this paper
• Estrogen receptor null mice: what have we learned and where will they lead us?

  1999cited by this paper
• Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.

  1999cited by this paper
• STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone*

  1999cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.

  1999cited by this paper
• Further Characterization of Cells Expressing STRO‐1 in Cultures of Adult Human Bone Marrow Stromal Cells

  1999cited by this paper
• Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

  1999cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998influential reference
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Development and characterization of a conditionally transformed adult human osteoblastic cell line

  1996cited by this paper
• Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β

  1996cited by this paper
• Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

  1996influential reference
• New York, New York, USA

  1996cited by this paper
• Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow

  1995cited by this paper
• Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

  1994cited by this paper
• Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.

  1994cited by this paper
• The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors.

  1994cited by this paper
• Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

  1993cited by this paper
• Pathology of bone marrow

  1992cited by this paper
• Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone

  1991cited by this paper
• Modulation of Transforming Growth Factor-/? Production in Normal Human Osteoblast-Like Cells by 17/?-Estradiol and Parathyroid Hormone

  1991cited by this paper
• Formation of osteoblast‐like cells from human mononuclear bone marrow cultures

  1991cited by this paper
• Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone.

  1991cited by this paper
• Leucocyte typing IV : white cell differentiation antigens

  1989cited by this paper
• Stromal stem cells: marrow-derived osteogenic precursors.

  1988cited by this paper

• Estradiol regulates osteoclast sialylation via ST3Gal1 in postmenopausal osteoporosis

  2026cites this paper
• Traditional Chinese Medicine for osteoporosis management: from molecular mechanisms to drug discovery

  2026cites this paper
• A review of the relationship between gut microbiota and osteoporosis in high altitude environments

  2025cites this paper
• The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans—a histomorphometry centered scoping review

  2025cites this paper
• Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice

  2025cites this paper
• RANK/RANKL Signaling Pathway in Breast Development and Cancer.

  2025cites this paper
• Comparison of Efficacy and Safety of Romosozumab versus Denosumab for Treatment of Postmenopausal Osteoporosis: A Meta-analysis

  2025cites this paper
• Research Progress in the Etiology of Primary Osteoporosis

  2025cites this paper
• Circulating tumor cells in breast cancer bone metastasis: mechanisms, clinical relevance, and future directions

  2025cites this paper
• A Literature Review on the Effects of Different Types of Exercise on Bone Metabolism

  2025cites this paper
• BPAG1 promotes osteoclastogenesis and postmenopausal osteoporosis via activating ERK signaling pathway

  2025cites this paper
• RANKL promotes MT2 degradation and ROS production in osteoclast precursors through Beclin1-dependent autophagy.

  2025cites this paper
• Mechanisms and traditional Chinese medicine therapeutics for primary osteoporosis: an integrated perspective

  2025cites this paper
• The immune thrombocytopenia therapeutic Avatrombopag alleviates osteoporosis by targeting NFATc1 signaling.

  2025cites this paper
• Dietary fiber derived short-chain fatty acids as a critical driver of the gut–bone axis in animal bone health: A review

  2025cites this paper
• Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis

  2025cites this paper
• RANK LIGAND-OSTEOPROTEGRIN SYSTEM AS A DIAGNOSTIC TOOL IN OSTEOPOROSIS

  2025cites this paper
• Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?

  2025cites this paper
• The role of probiotics in modulating RANKL in osteoporosis: A systematic review of animal interventional studies and RCTs.

  2025cites this paper
• Bioactive Glass Modified by Sonochemistry Improves Peri-Implant Bone Repair in Ovariectomized Rats

  2025cites this paper
• Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders

  2025cites this paper
• Non-pyroptotic caspase-11 activity regulates osteoclastogenesis and pathological bone loss.

  2025cites this paper
• Menopause in Cystic Fibrosis: Special considerations for bone health, menopausal symptoms, and treatment.

  2025cites this paper
• The Crosstalk Between B Cells and the Skeletal System During Development, Aging, and in Pathological Conditions

  2025cites this paper
• The gut microbiota in osteoporosis: dual roles and therapeutic prospects

  2025cites this paper
• Regulatory cellular and molecular networks in the bone microenvironment during aging

  2024cites this paper
• Advances in mechanobiological pharmacokinetic-pharmacodynamic models of osteoporosis treatment - Pathways to optimise and exploit existing therapies.

  2024cites this paper
• The multi-faceted nature of age-associated osteoporosis

  2024cites this paper
• An in silico approach to elucidate the pathways leading to primary osteoporosis: age-related vs. postmenopausal

  2024influential citation
• Probiotics enhance alveolar bone microarchitecture, intestinal morphology and estradiol levels in osteoporotic animals.

  2024cites this paper
• Associations Among Estrogens, the Gut Microbiome and Osteoporosis

  2024cites this paper
• Heterotopic Mineralization (Ossification or Calcification) in Aged Musculoskeletal Soft Tissues: a New Candidate Marker for Aging.

  2024cites this paper
• Effects of Growth Hormone on Osteoarthritis Development

  2024cites this paper
• Elucidating common biomarkers and pathways of osteoporosis and aortic valve calcification: insights into new therapeutic targets

  2024cites this paper
• Is there a role for essential fatty acids in osteoporosis?

  2024cites this paper
• Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal Osteoporosis

  2024cites this paper
• A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence

  2024cites this paper
• Advances in the Study of Denosumab Treatment for Osteoporosis and Sarcopenia in the Chinese Middle-Aged and Elderly Population

  2024cites this paper
• The p53-miR17 family-Rankl axis bridges liver-bone communication.

  2024cites this paper
• Mechanisms for Sex-Specific Effects of THRβ Signaling in Modifying Metabolic Effects of High Fat Diet in Mice.

  2024cites this paper
• Emerging roles of osteocytes in regulation of bone and skeletal muscle mass.

  2024cites this paper
• GalNAc-Conjugated siRNA Targeting Complement C3 Inhibits Osteoclast Activation in Periodontitis.

  2024cites this paper
• Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism

  2024cites this paper
• Bone Loss and Fractures in Post-Menopausal Women Living with HIV: A Narrative Review

  2024cites this paper
• Cardenolides; Calotropin and Gomphogenin from Calotropis procera (Aiton) mitigate bone turnover in Ovariectomized osteoporotic rats: Targeting RANKL/OPG axis and estrogen receptor-alpha.

  2024cites this paper
• The Potential of Indole Alkaloids in Bone Health and Osteoporosis Management

  2024cites this paper
• Vertebral marrow fat fraction is associated with circulating RANKL in postmenopausal females

  2024cites this paper
• Age-related bone diseases: Role of inflammaging.

  2024cites this paper
• Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice

  2024cites this paper
• RANK IVVY motif plays crucial roles in osteoclastogenesis.

  2024cites this paper
• A mechanobiological bone remodelling model coupling bone physiology and systemic calcium and phosphorus homeostasis

  2023cites this paper
• Anti–NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice

  2023cites this paper
• The detection of Gper1 as an important gene promoting jawbone regeneration in the context of estrogen deficiency.

  2023cites this paper
• Eicosapentaenoic acid supplementation modulates the osteoblast/osteoclast balance in inflammatory environments and protects against estrogen deficiency-induced bone loss in mice.

  2023cites this paper
• Evidence in Humans for Bone as an Endocrine Organ Regulating Energy Metabolism.

  2023cites this paper
• Alloferon-1 ameliorates estrogen deficiency-induced osteoporosis through dampening the NLRP3/caspase-1/IL-1β/IL-18 signaling pathway.

  2023cites this paper
• Determining a multimodal aging clock in a cohort of Chinese women.

  2023cites this paper
• Osteoinduction and osteoimmunology: Emerging concepts.

  2023cites this paper
• Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis

  2023cites this paper
• Jiangu granules ameliorate postmenopausal osteoporosis via rectifying bone homeostasis imbalance: A network pharmacology analysis based on multi-omics validation.

  2023cites this paper
• Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice

  2023cites this paper
• Study on the mechanism of NLRP3 effect on the skeleton of de-ovalized mice

  2023cites this paper
• Inflammation and gut dysbiosis as drivers of CKD–MBD

  2023cites this paper
• Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone

  2023cites this paper
• Single-cell RNA sequencing reveals in vivo osteoimmunology interactions between the immune and skeletal systems

  2023cites this paper
• Role of the Osteocyte in Musculoskeletal Disease

  2023cites this paper
• Pulsed frequency modulated ultrasound promotes therapeutic effects of osteoporosis induced by ovarian failure in mice.

  2023cites this paper
• Mechanistic advances in osteoporosis and anti‐osteoporosis therapies

  2023cites this paper
• Aging and Bone Metabolism.

  2023cites this paper
• Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies.

  2023cites this paper
• Cooperation between T and B cells reinforce the establishment of bone metastases in a mouse model of breast cancer.

  2023cites this paper
• Quality of life in postmenopausal women with osteoporosis and osteopenia: associations with bone microarchitecture and nutritional status

  2023cites this paper
• Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis

  2022cites this paper
• Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study

  2022cites this paper
• Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis

  2022cites this paper
• A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases

  2022cites this paper
• Osteoclasts directly influence castration-resistant prostate cancer cells

  2022cites this paper
• Sulfated Glucuronorhamnoxylan from Capsosiphon fulvescens Ameliorates Osteoporotic Bone Resorption via Inhibition of Osteoclastic Cell Differentiation and Function In Vitro and In Vivo

  2022cites this paper
• Postmenopausal Osteoporosis: A Literature Review

  2022cites this paper
• Clinical Data for Parametrization of In Silico Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature

  2022cites this paper
• Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice

  2022cites this paper
• Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis

  2022cites this paper
• The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease

  2022cites this paper
• The impact of sex steroids on osteonecrosis of the jaw

  2022cites this paper
• Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS

  2022cites this paper
• Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases

  2022cites this paper
• Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus

  2022cites this paper
• Assessing the bone-healing potential of bone marrow mesenchymal stem cells in jawbone osteoporosis in albino rats.

  2022cites this paper
• Emerging antiresorptive medications and their potential implications for dental surgeries.

  2022cites this paper
• Engineered extracellular vesicles for bone therapy

  2022cites this paper
• N-Butanol Extract of Modified You-Gui-Yin Attenuates Osteoclastogenesis and Ameliorates Osteoporosis by Inhibiting RANKL-Mediated NF-κB Signaling

  2022cites this paper
• Genetic Association of rs1021188 and DNA Methylation Signatures of TNFSF11 in the Risk of Conductive Hearing Loss

  2022cites this paper
• The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis

  2022cites this paper
• Effects of Estrogens on Osteoimmunology: A Role in Bone Metastasis

  2022cites this paper
• Heat-Killed Lacticaseibacillus paracasei GMNL-653 Exerts Antiosteoporotic Effects by Restoring the Gut Microbiota Dysbiosis in Ovariectomized Mice

  2022cites this paper
• Cellular senescence and the skeleton: pathophysiology and therapeutic implications

  2022cites this paper
• Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis

  2022cites this paper
• Callus formation in albino Wistar rats after femur fracture assessed by visible spectroscopy.

  2022cites this paper
• Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis

  2022cites this paper
• Endocrinology of Bone and Growth Disorders

  2021cites this paper